175 related articles for article (PubMed ID: 10233903)
21. Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells.
Würflein D; Dechant M; Stockmeyer B; Tutt AL; Hu P; Repp R; Kalden JR; van de Winkel JG; Epstein AL; Valerius T; Glennie M; Gramatzki M
Cancer Res; 1998 Jul; 58(14):3051-8. PubMed ID: 9679970
[TBL] [Abstract][Full Text] [Related]
22. Cytokine influence on killing of fresh chronic lymphocytic leukemia cells by human leukocytes.
Cemerlíc D; Dadey B; Han T; Vaickus L
Blood; 1991 Jun; 77(12):2707-15. PubMed ID: 1904285
[TBL] [Abstract][Full Text] [Related]
23. Chimeric CLL-1 antibody fusion proteins containing granulocyte-macrophage colony-stimulating factor or interleukin-2 with specificity for B-cell malignancies exhibit enhanced effector functions while retaining tumor targeting properties.
Hornick JL; Khawli LA; Hu P; Lynch M; Anderson PM; Epstein AL
Blood; 1997 Jun; 89(12):4437-47. PubMed ID: 9192768
[TBL] [Abstract][Full Text] [Related]
24. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor.
Horie S; Kita H
J Immunol; 1994 Jun; 152(11):5457-67. PubMed ID: 7514638
[TBL] [Abstract][Full Text] [Related]
25. Expression of neutrophil antigens after 10 days of granulocyte-colony-stimulating factor.
Stroncek DF; Jaszcz W; Herr GP; Clay ME; McCullough J
Transfusion; 1998 Jul; 38(7):663-8. PubMed ID: 9683105
[TBL] [Abstract][Full Text] [Related]
26. Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion.
Xia Y; Borland G; Huang J; Mizukami IF; Petty HR; Todd RF; Ross GD
J Immunol; 2002 Dec; 169(11):6417-26. PubMed ID: 12444150
[TBL] [Abstract][Full Text] [Related]
27. Neutrophils activated by granulocyte-macrophage colony-stimulating factor express receptors for interleukin-3 which mediate class II expression.
Smith WB; Guida L; Sun Q; Korpelainen EI; van den Heuvel C; Gillis D; Hawrylowicz CM; Vadas MA; Lopez AF
Blood; 1995 Nov; 86(10):3938-44. PubMed ID: 7579364
[TBL] [Abstract][Full Text] [Related]
28. Target cell-induced apoptosis of interleukin-2-activated human natural killer cells: roles of cell surface molecules and intracellular events.
Yamauchi A; Taga K; Mostowski HS; Bloom ET
Blood; 1996 Jun; 87(12):5127-35. PubMed ID: 8652825
[TBL] [Abstract][Full Text] [Related]
29. Human neutrophils are selectively activated by independent ligation of the subunits of the CD11b/CD18 integrin.
Petersen MM; Steadman R; Williams JD
J Leukoc Biol; 1994 Dec; 56(6):708-13. PubMed ID: 7527829
[TBL] [Abstract][Full Text] [Related]
30. Antibodies against human neutrophil LECAM-1 (LAM-1/Leu-8/DREG-56 antigen) and endothelial cell ELAM-1 inhibit a common CD18-independent adhesion pathway in vitro.
Kishimoto TK; Warnock RA; Jutila MA; Butcher EC; Lane C; Anderson DC; Smith CW
Blood; 1991 Aug; 78(3):805-11. PubMed ID: 1713515
[TBL] [Abstract][Full Text] [Related]
31. Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy.
Stockmeyer B; Dechant M; van Egmond M; Tutt AL; Sundarapandiyan K; Graziano RF; Repp R; Kalden JR; Gramatzki M; Glennie MJ; van de Winkel JG; Valerius T
J Immunol; 2000 Nov; 165(10):5954-61. PubMed ID: 11067958
[TBL] [Abstract][Full Text] [Related]
32. Continuous activation and deactivation of integrin CD11b/CD18 during de novo expression enables rolling neutrophils to immobilize on platelets.
Sheikh S; Nash GB
Blood; 1996 Jun; 87(12):5040-50. PubMed ID: 8652817
[TBL] [Abstract][Full Text] [Related]
33. A monoclonal antibody to a novel surface antigen, MKW, blocks the antiproliferative and differentiation effects of granulocyte-macrophagecolony-stimulating factor and vitamin D3.
Koehler M; Goorha R; Kitchingman GR; Ayers GD; Mirro J
Blood; 1992 Jul; 80(2):367-73. PubMed ID: 1320952
[TBL] [Abstract][Full Text] [Related]
34. Activated phenotype in neutrophils and monocytes from patients with primary proliferative polycythaemia.
Westwood NB; Copson ER; Page LA; Mire-Sluis AR; Brown KA; Pearson TC
J Clin Pathol; 1995 Jun; 48(6):525-30. PubMed ID: 7545186
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies.
Ragnhammar P; Frödin JE; Trotta PP; Mellstedt H
Cancer Immunol Immunother; 1994 Oct; 39(4):254-62. PubMed ID: 7525059
[TBL] [Abstract][Full Text] [Related]
36. Cross-linking of CD18 primes human neutrophils for activation of the respiratory burst in response to specific stimuli: implications for adhesion-dependent physiological responses in neutrophils.
Liles WC; Ledbetter JA; Waltersdorph AW; Klebanoff SJ
J Leukoc Biol; 1995 Dec; 58(6):690-7. PubMed ID: 7499967
[TBL] [Abstract][Full Text] [Related]
37. Enhanced adherence activity of OK-432-induced peritoneal neutrophils to tumor cells correlates to their increased expression of CD11b/CD18.
Morisaki T; Torisu M
Clin Immunol Immunopathol; 1991 Jun; 59(3):474-86. PubMed ID: 1674240
[TBL] [Abstract][Full Text] [Related]
38. Antibody to Mol abrogates the increase in neutrophil phagocytosis and degranulation induced by granulocyte-macrophage colony-stimulating factor.
Kletter Y; Bleiberg I; Golde DW; Fabian I
Eur J Haematol; 1989 Nov; 43(5):389-96. PubMed ID: 2482194
[TBL] [Abstract][Full Text] [Related]
39. Enhanced expression of integrins and CD66b on peripheral blood neutrophils and eosinophils in patients with rheumatoid arthritis, and the effect of glucocorticoids.
Torsteinsdóttir I; Arvidson NG; Hällgren R; Håkansson L
Scand J Immunol; 1999 Oct; 50(4):433-9. PubMed ID: 10520185
[TBL] [Abstract][Full Text] [Related]
40. Granulocyte colony-stimulating factor (G-CSF) increases neutrophil migration across vascular endothelium independent of an effect on adhesion: comparison with granulocyte-macrophage colony-stimulating factor (GM-CSF).
Yong KL
Br J Haematol; 1996 Jul; 94(1):40-7. PubMed ID: 8757506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
